More tools:Markets·Screener·Research·Chat

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Financial Statements

Drugs Made In America Acquisition II Corp. Ordinary Shares
SIC 6770 · BLANK CHECKS
FIGI AK-B1961DE845
XNAS · usd
10.17▼ 0.01 (-0.05%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)—
EBITDA—
Diluted EPS (TTM)—
EBITDA Margin—
Net Debt—
Trading Information
Previous Close10.17
Day's Range10.16 – 10.17
52-Week Range9.86 – 10.21
Volume4,318
Avg Volume71.1K
Share Statistics
Shares Outstanding
Employees2
ExchangeXNAS
Listed2025-12-03
Share count as of August 14, 2026
Loading Income Statement…
Key questions about Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
What is Drugs Made In America Acquisition II Corp. Ordinary Shares's Market Cap?
Drugs Made In America Acquisition II Corp. Ordinary Shares's Market Cap is $647.5M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Operating expenses
General and administrative costs
Total operating expenses——
Loss from operations
Other income
Interest earned on cash and investments held in Trust Account
Recovery of credit losses——
Total other income
Net income (loss)
Basic net income (loss) per ordinary share——
Diluted net income (loss) per ordinary share——